AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
Evaluation of the United States food and drug administration-approved scoring and test system of HER-2 protein expression in breast cancer
Authors: Birner, P Oberhuber, G Stani, J Reithofer, C Samonigg, H Hausmaninger, H Kubista, E Kwasny, W Kandioler-Eckersberger, D Gnant, M Jakesz, R
Citation: P. Birner et al., Evaluation of the United States food and drug administration-approved scoring and test system of HER-2 protein expression in breast cancer, CLIN CANC R, 7(6), 2001, pp. 1669-1675
Prognostic relevance of three histological grading methods in breast cancer
Authors: Latinovic, L Heinze, G Birner, P Samonigg, H Hausmaninger, H Kubista, E Kwasny, W Gnant, M Jakesz, R Oberhuber, G
Citation: L. Latinovic et al., Prognostic relevance of three histological grading methods in breast cancer, INT J ONCOL, 19(6), 2001, pp. 1271-1277
Color Doppler sonography of the lateral thoracic (breast-feeding) arteries: a new approach to the diagnosis of breast disease?
Authors: Obwegeser, R Berghammer, P Lorenz, K Auerbach, L Kubista, E
Citation: R. Obwegeser et al., Color Doppler sonography of the lateral thoracic (breast-feeding) arteries: a new approach to the diagnosis of breast disease?, ULTRASOUN O, 18(5), 2001, pp. 515-519
Comparative analysis of two-dimensional protein patterns in malignant and normal human breast tissue
Authors: Czerwenka, KF Manavi, M Hosmann, J Jelincic, D Pischinger, KID Battistutti, WB Behnam, M Kubista, E
Citation: Kf. Czerwenka et al., Comparative analysis of two-dimensional protein patterns in malignant and normal human breast tissue, CANCER DET, 25(3), 2001, pp. 268-279
Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial
Authors: Schmidinger, M Budinsky, AC Wenzel, C Locker, GJ Pluschnig, U Brodowicz, T Kubista, E Maca, S Zabernigg, A Ilsinger, P Seewann, L Hojas, S Blach, M Zielinski, CC Steger, GG
Citation: M. Schmidinger et al., Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial, CANC CHEMOT, 47(1), 2001, pp. 57-62
Sealing of postoperative axillary leakage after axillary lymphadenectomy using a fibrin glue coated collagen patch: a prospective randomised study
Authors: Berger, A Tempfer, C Hartmann, B Kornprat, P Rossmann, A Neuwirth, G Tulusan, A Kubista, E
Citation: A. Berger et al., Sealing of postoperative axillary leakage after axillary lymphadenectomy using a fibrin glue coated collagen patch: a prospective randomised study, BREAST CANC, 67(1), 2001, pp. 9-14
Tamoxifen and risk of endometrial cancer
Authors: Tempfer, C Kubista, E
Citation: C. Tempfer et E. Kubista, Tamoxifen and risk of endometrial cancer, LANCET, 357(9249), 2001, pp. 65-65
Statistical modeling of the LMS channel
Authors: Fontan, FP Vazquez-Castro, M Cabado, CE Garcia, JP Kubista, E
Citation: Fp. Fontan et al., Statistical modeling of the LMS channel, IEEE VEH T, 50(6), 2001, pp. 1549-1567
Circulating breast cancer cells are frequently apoptotic
Authors: Mehes, G Witt, A Kubista, E Ambros, PF
Citation: G. Mehes et al., Circulating breast cancer cells are frequently apoptotic, AM J PATH, 159(1), 2001, pp. 17-20
Single-agent gemcitabine as second- and third-line treatment in metastaticbreast cancer
Authors: Brodowicz, T Kostler, WJ Moslinger, R Tomek, S Vaclavik, I Herscovici, V Wiltschke, C Steger, GG Wein, W Seifert, M Kubista, E Zielinski, CC
Citation: T. Brodowicz et al., Single-agent gemcitabine as second- and third-line treatment in metastaticbreast cancer, BREAST, 9(6), 2000, pp. 338-342
The oestrogen receptor and its selective modulators in gynaecological oncology
Authors: Seifert, M Galid, A Kubista, E
Citation: M. Seifert et al., The oestrogen receptor and its selective modulators in gynaecological oncology, EUR J CANC, 36, 2000, pp. S66-S67
Axillary lymph nodes in breast cancer: Is size related to metastatic involvement?
Authors: Obwegeser, R Lorenz, K Hohlagschwandtner, M Czerwenka, K Schneider, B Kubista, E
Citation: R. Obwegeser et al., Axillary lymph nodes in breast cancer: Is size related to metastatic involvement?, WORLD J SUR, 24(5), 2000, pp. 546-550
Paclitaxel-containing high-dose chemotherapy in high-risk breast cancer patients
Authors: Greinix, HT Linkesch, W Seifert, M Kubista, E Czerwenka, K Elahi, F Zielinski, C Hoecker, P Steger, G Schulenburg, A Neumeister, G Rabitsch, W Jakesz, R Kalhs, P
Citation: Ht. Greinix et al., Paclitaxel-containing high-dose chemotherapy in high-risk breast cancer patients, ACTA ONCOL, 39(1), 2000, pp. 47-52
Local feedback mechanisms in human breast cancer
Authors: Singer, CF Kubista, E Garmroudi, F Cullen, KJ
Citation: Cf. Singer et al., Local feedback mechanisms in human breast cancer, BREAST CANC, 63(2), 2000, pp. 95-104
99m-Tc-tetrofosmin scintigraphy for the evaluation of suspicious palpable and non-palpable breast lesions
Authors: Obwegeser, R Berghammer, P Muellauer-Ertl, S Kubista, E Sinzinger, H
Citation: R. Obwegeser et al., 99m-Tc-tetrofosmin scintigraphy for the evaluation of suspicious palpable and non-palpable breast lesions, BREAST CANC, 62(3), 2000, pp. 253-258
Use of Tc-99m-furifosmin scintigraphy - Planar and SPECT - to evaluate suggestive palpable and nonpalpable breast lesions
Authors: Obwegeser, R Berghammer, P Rodrigues, M Kubista, E Sinzinger, H
Citation: R. Obwegeser et al., Use of Tc-99m-furifosmin scintigraphy - Planar and SPECT - to evaluate suggestive palpable and nonpalpable breast lesions, J NUCL MED, 41(3), 2000, pp. 426-428
Ka-band propagation measurements and statistics for land mobile satellite applications
Authors: Kubista, E Fontan, FP Castro, MAV Buonomo, S Arbesser-Rastburg, BR Baptista, JPVP
Citation: E. Kubista et al., Ka-band propagation measurements and statistics for land mobile satellite applications, IEEE VEH T, 49(3), 2000, pp. 973-983
Classification of isolated tumor cells and micrometastasis
Authors: Mehes, G Witt, A Kubista, E Ambros, PF
Citation: G. Mehes et al., Classification of isolated tumor cells and micrometastasis, CANCER, 89(3), 2000, pp. 709-711
Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer
Authors: Tong, D Schneeberger, C Czerwenka, K Schmutzler, RK Speiser, P Kucera, E Concin, N Kubista, E Leodolter, S Zeillinger, R
Citation: D. Tong et al., Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer, CLIN CANC R, 5(6), 1999, pp. 1497-1502
Growth inhibition by dehydrothyrsiferol - a non-Pgp modulator, derived from a marine red alga - in human breast cancer cell lines
Authors: Pec, MK Moser-Thier, K Fernandez, JJ Souto, ML Kubista, E
Citation: Mk. Pec et al., Growth inhibition by dehydrothyrsiferol - a non-Pgp modulator, derived from a marine red alga - in human breast cancer cell lines, INT J ONCOL, 14(4), 1999, pp. 739-743
Guidelines of the arbeitsgemeinschaft gynakologische onkologie for the treatment of breast cancer
Authors: Concin, H Grunberger, W Kubista, E Menzel, C Pickel, H Reiner, A Seitz, W Sevelda, P Staudach, A Widschwendter, M Wolf, G
Citation: H. Concin et al., Guidelines of the arbeitsgemeinschaft gynakologische onkologie for the treatment of breast cancer, GYNAKOL GEB, 39(4), 1999, pp. 226-229
Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations (vol 8, pg 413, 1999)
Authors: Wagner, TMU Hirtenlehner, K Shen, PD Moeslinger, R Muhr, D Fleischmann, E Concin, H Doeller, W Haid, A Lang, AH Mayer, P Petru, E Ropp, E Langbauer, G Kubista, E Scheiner, O Underhill, P Mountain, J Stierer, M Zielinski, C Oefner, P
Citation: Tmu. Wagner et al., Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations (vol 8, pg 413, 1999), HUM MOL GEN, 8(4), 1999, pp. 717-719
Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations
Authors: Wagner, TMU Hirtenlehner, K Shen, PD Moeslinger, R Muhr, D Fleischmann, E Concin, H Doeller, W Haid, A Lang, AH Mayer, P Petru, E Ropp, E Langbauer, G Kubista, E Scheiner, O Underhill, P Mountain, J Stierer, M Zielinski, C Oefner, P
Citation: Tmu. Wagner et al., Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations, HUM MOL GEN, 8(3), 1999, pp. 413-423
Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients
Authors: Kucera, E Speiser, P Gnant, M Szabo, L Samonigg, H Hausmaninger, H Mittlbock, M Fridrik, M Seifert, M Kubista, E Reiner, A Zeillinger, R Jakesz, R
Citation: E. Kucera et al., Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients, EUR J CANC, 35(3), 1999, pp. 398-405
Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer
Authors: Jakesz, R Hausmaninger, H Haider, K Kubista, E Samonigg, H Gnant, M Manfreda, D Tschurtschenthaler, G Kolb, R Stierer, M Fridrik, M Mlineritsch, B Steindorfer, P Mittlbock, M Steger, G
Citation: R. Jakesz et al., Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer, J CL ONCOL, 17(6), 1999, pp. 1701-1709
Risultati: 1-25 | 26-35